您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2020, Vol. 58 ›› Issue (7): 24-31.doi: 10.6040/j.issn.1671-7554.0.2020.0102

• • 上一篇    

Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制

付洁琦,张曼,张晓璐,李卉,陈红   

  • 发布日期:2020-07-10
  • 通讯作者: 张曼. E-mail:zhangm0046@163.com; 陈红. E-mail:chenhong977@hotmail.com
  • 基金资助:
    辽宁省科技厅课题(201705040869,201705040881);沈阳市科技局课题(17-230-9-32,17-230-9-70);沈阳医学院课题(20181008);沈阳医学院研究生课题(Y20180509)

Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ

FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong   

  1. Department of MICU, Central Hospital Affiliated To Shenyang Medical College, Shenyang 110024, Liaoning, China
  • Published:2020-07-10

摘要: 目的 选取高脂饮食模型大鼠和氧化低密度脂蛋白(oxLDL)暴露下巨噬细胞模型,验证在血脂蓄积过程中Toll样受体4(TLR4)和过氧化物酶体增殖物激活受体γ(PPARγ)的具体干预机制。 方法 健康雄性Wistar大鼠20只,随机分为对照组和高脂组,每组10只。测定各组大鼠总胆固醇、甘油三酯、高密度脂蛋白、低密度脂蛋白水平,采用苏木精-伊红染色检测颈动脉血管内膜中膜厚度比,采用Western blotting法检测TLR4、PPARγ蛋白表达水平。体外培养小鼠巨噬细胞RAW264.7,以oxLDL(50 mg/L)刺激巨噬细胞制备模型,且应用siRNA-TLR4沉默巨噬细胞内的TLR4因子制备TLR4沉默模型,将细胞分为空白组(A组)、oxLDL组(B组)、oxLDL+siRNA组(C组)、oxLDL+siRNA-TLR4组(D组)、oxLDL+siRNA-TLR4+PPARγ激动剂组(E组)、oxLDL+siRNA-TLR4+PPARγ抑制剂组(F组)。采用油红O染色法观察巨噬细胞内血脂蓄积情况,定量检测巨噬细胞内胆固醇含量,采用Western blotting法检测 TLR4、PPARγ蛋白表达水平。 结果 在动物模型实验中,与对照组相比,高脂组总胆固醇、甘油三酯、低密度脂蛋白水平、颈动脉内膜中膜厚度比、TLR4蛋白相对表达含量明显增高(P<0.01),血清高密度脂蛋白水平、PPARγ蛋白相对表达含量明显降低(P<0.01),且TLR4与PPARγ呈负相关性(r=-0.928 1,P<0.001)。在oxLDL暴露巨噬细胞实验中,与A组比较,B、C组巨噬细胞内胆固醇含量、油红O颗粒、光密度值及TLR4蛋白相对表达含量明显增多(P<0.01),PPARγ蛋白相对表达含量明显减少(P<0.05),且B组TLR4与PPARγ呈负相关性(r=-0.986 7,P<0.001)。与B组相比,C组巨噬细胞内胆固醇含量、油红O颗粒、光密度值及TLR4、PPARγ蛋白相对表达含量未见明显改变(P>0.05)。与B组相比,D组巨噬细胞内胆固醇含量、油红O颗粒及光密度值及TLR4蛋白相对表达含量明显减少(P<0.01),PPARγ蛋白相对表达含量明显增多(P<0.05)。与D组相比,E组巨噬细胞内胆固醇含量、油红O颗粒及光密度值明显减少(P<0.01),PPARγ蛋白相对表达含量明显增多(P<0.05),TLR4蛋白相对表达含量未见明显改变(P>0.05)。与D组相比,F组巨噬细胞内胆固醇含量、油红O颗粒及光密度值明显增多(P<0.01),PPARγ蛋白相对表达含量明显减少(P<0.05),TLR4蛋白相对表达含量未见明显改变(P>0.05)。 结论 细胞内的血脂蓄积是动脉粥样硬化形成的机制之一,PPARγ可以抑制巨噬细胞血脂蓄积进而参与动脉粥样硬化调节,是巨噬细胞血脂蓄积过程的保护性因子。而TLR4作为PPARγ上游调控位点,通过抑制PPARγ的表达,加重血脂蓄积的过程,进而干预动脉粥样硬化进程。

关键词: 氧化低密度脂蛋白, Toll样受体4, 过氧化物酶体增殖物激活受体γ, 动脉粥样硬化, 血脂, 胆固醇, 巨噬细胞, 基因沉默

Abstract: Objective To investigate the molecular mechanism of Toll-like receptor 4(TLR4)and peroxisome proliferator-activated receptor γ(PPARγ)in the process of lipid accumulation in rat models of high-fat diet and oxidized low-density lipoprotein(oxLDL). Methods A total of 20 healthy male Wistar rats were randomly divided into control group(n=10)and high fat group(n=10). Total cholesterol(TG), triglycerides(TC), high-density lipoprotein(HDL)and low-density lipoprotein(LDL)levels were measured in both groups. The carotid intima-media thickness ratio was detected with HE staining, and the protein expressions of TLR4 and PPARγ were determined with Western blotting. Rat macrophages RAW264.7 were cultured in vitro and stimulated by oxLDL(50 mg/L)to prepare the macrophage models, and TLR4 factors in the macrophages were silenced with siRNA-TLR4 to prepare the TLR4 silencing models. The cells were divided into blank group(group A), oxLDL group(group B), oxLDL+siRNA group(group C), oxLDL+siRNA-TLR4 group(group D), oxLDL+siRNA-TLR4+PPARγ agonist group(group E)and oxLDL +siRNA-TLR4+PPARγ inhibitor group(group F). The lipid accumulation in macrophages was observed with oil red O staining, cholesterol level in macrophages was quantitatively detected, and protein expressions of TLR4 and PPARγ were tested with Western blotting. Results In the animal model experiments, compared with control group, high fat group had significantly increased levels of TG, TC, LDL, ratio of carotid intima-media thickness, and relative expression of TLR4(P<0.01), but decreased levels of serum HDL and PPARγ(P<0.01), and there was a negative correlation between TLR4 and PPARγ (r=-0.928 1, P<0.001). In the oxLDL exposure to macrophages experiments, compared with group A, groups B and C had significantly increased cholesterol content(P<0.01), oil red O particles, optical density(OD)value and relative expression of TLR4, but decreased relative expression of PPARγ (P<0.05). Besides, there was a negative correlation between TLR4 and PPARγ(r=-0.986 7, P<0.001)in group B. Compared with group B, group C had no significant changes in cholesterol content, oil red O particles, OD value and relative expressions of TLR4 and PPARγ(P>0.05). Compared with group B, group D had significantly decreased cholesterol content, oil red O particles, OD value and relative expression of TLR4(P<0.01), but significantly increased relative expression of PPARγ(P<0.05). Compared with group D, group E had significantly decreased cholesterol content, oil red O particles and OD value(P<0.01), but significantly increased relative expression of PPARγ(P<0.05), and the expression of TLR4 remained unchanged(P>0.05). Compared with group D, group F had significantly increased cholesterol content(P<0.01), oil red O particles and OD value, but significantly decreased relative expression of PPARγ(P<0.05), and the relative expression of TLR4 protein did not significantly change(P>0.05). Conclusion The accumulation of blood lipids in cells is involved in the pathogenesis of atherosclerosis(AS). As a protective factor, PPARγ can inhibit the accumulation of blood lipids in macrophages and then participate in AS regulation. As an upstream regulatory site of PPARγ, TLR4 aggravates lipid accumulation by inhibiting the expression of PPARγ, and then interferes with the progression of AS.

Key words: Oxidized low-density lipoprotein, Toll-like receptor 4, Peroxisome proliferator-activated receptor γ, Atherosclerosis, Blood lipids, Cholesterol, Macrophages, Gene silencing

中图分类号: 

  • R543.5
[1] 吕海辰, 刘基巍, 刘莹, 等. 肿瘤心脏病学领域指导临床实践的纲领性文件—— 2016年欧洲心脏病学会癌症治疗与心血管毒性立场声明解读[J]. 中国循环杂志, 2016, 31(2): 125-128.
[2] 张建祥. 纳米医学在动脉粥样硬化防治中的进展[J]. 第三军医大学学报, 2014, 36(2): 87-91. ZHANG Jianxiang. Nanomedicine in atherosclerosis management[J]. Third Military Medical University, 2014, 36(2): 87-91.
[3] 欧思琳, 李茹冰. NF-κB在动脉粥样硬化疾病中的研究进展[J]. 中国免疫学杂志, 2018, 34(7): 1095-1101. OU Silin, LI Rubing. Research Progress of mechanism of NF-κB in atherosclerosis[J]. Chinese Journal of Immunology, 2018, 34(7): 1095-1101.
[4] 尹婕, 李琦, 赵正, 等. 纤维化对动脉粥样硬化斑块稳定性的基础研究及相关药物应用[J]. 中国中药杂志, 2019, 44(2): 235-241. YIN Jie, LI Qi, ZHAO Zheng, et al. Basic research of fibrosis on atherosclerotic plaque stability and related drug application[J]. China Journal of Chinese Materia Medica, 2019, 44(2): 235-241.
[5] Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel[J]. Eur Heart J, 2017, 38(32): 2459-2472.
[6] Hao S, Ji J, Zhao H, et al. Mitochondrion-targeted peptide SS-31 inhibited oxidized lowdensity lipoproteins-induced foam cell formation through both ros scavenging and inhibition of cholesterol influx in RAW264.7 cells[J]. Molecules, 2015, 20(12): 21287-21297.
[7] Yin YW, Liao SQ, Zhang MJ, et al. TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression[J]. Cell Death Dis, 2015, 6(2): 1659.
[8] Lin J, Liu Q, Zhang H, et al. C1q/Tumor necrosis factor-related protein-3 protects macrophages against LPS-induced lipid accumulation, inflammation and phenotype transition via PPARγ and TLR4-mediated pathways[J]. Oncotarget, 2017, 8(47): 82541-82557.
[9] Ho MM, Manughian-Peter A, Spivia WR, et al. Macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins are modulated by complement protein C1q[J]. Atherosclerosis, 2016, 253: 38-46. doi:10.1016/j.atherosclerosis.
[10] Miller YI, Shyy JY. Context-dependent role of oxidized lipids and lipoproteins in inflammation[J]. Trends Endocrinol Metab, 2017, 28(2): 143-152.
[11] 高丽娜. Toll样受体4介导的巨噬细胞泡沫化与动脉粥样硬化[J]. 济宁医学院学报, 2018, 41(3): 153-157. GAO Lina. Effects of toll-like receptor 4 mediated macrophage foam cells in atherosclerosis[J]. Journal of Jining Medical University, 2018, 41(3): 153-157.
[12] 杨如意, 周盼盼, 王宏斌, 等. 四味余甘子方对高脂血症大鼠抗过氧化及血脂水平的影响[J]. 中国中西医结合急救杂志, 2019, 31(4): 389-392. YANG Ruyi, ZHOU Panpan, WANG Hongbin, et al. Effects of Siweiyuganzi prescription on anti-peroxidation and blood lipid levels in rats with hyperlipidemia[J]. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care, 2019, 31(4): 389-392.
[13] 赵娅, 张松, 李媛媛, 等. 有氧运动对高脂血症大鼠血脂的影响及其机制[J].第二军医大学学报, 2019, 40(4): 412-419. ZHAO Ya, ZHANG Song, LI Yuanyuan, et al. Effect of aerobic exercise on blood lipid of hyperlipidemia rats and its mechanism[J]. Academic Journal of Second Military Medical University, 2019, 40(4): 412-419.
[14] Wu J, Zhang H, Zheng H, et al. Hepatic inflammation scores correlate with common carotid intima-media thickness in rats with NAFLD induced by a high-fat diet[J]. BMC Vet Res, 2014, 10(1): 162.
[15] 朱晓莹, 李昭, 胡健. 阿托伐他汀对糖尿病大鼠胸主动脉TLR4表达影响的实验研究[J]. 中国医药指南, 2014, 12(36): 19. ZHU Xiaoying, LI Zhao, HU Jian. Experimental study of the effect of atorvastatin on the expression of TLR4 in aorta thoracalis of the GK mice[J]. Guide of China Medicine, 2014, 12(36): 19.
[16] 王创畅, 吴伟, 魏伟超, 等. 清热、活血中药调控TLR4/MyD88/NF-κB信号干预动脉粥样硬化大鼠模型的实验研究[J]. 中华中医药学刊, 2018, 36(3): 576-580. WANG Chuangchang, WU Wei, WEI Weichao, et al. Experimental study of heat-clearing, blood-activating traditional Chinese drug regulating TLR4/MyD88/NF-κB signaling pathway on atherosclerosis rats[J]. Chinese Archives of Traditional Chinese Medicine, 2018, 36(3): 576-580.
[17] 蔡宏文, 缪静, 周鑫斌, 等. 痰瘀同治方调控PPARγ/NF-κB通路对大鼠动脉粥样硬化斑块内血管新生的影响[J]. 中国中西医结合杂志, 2017, 37(5): 579-583. CAI Hongwen, MIAO Jing, ZHOU Xinbin, et al. Effect of tanyu tongzhi recipe on angiogenesis in atherosclerosis plaque rats by regulating PPARγ/NF-κB pathways[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2017, 37(5): 579-583.
[18] 郑伟, 陈欣, 李亚新, 等. 别嘌呤醇抑制巨噬细胞血脂蓄积的作用机制[J]. 中国动脉硬化杂志, 2016, 24(4): 355-360. ZHENG Wei, CHEN Xin, LI Yaxin, et al. Study on the mechanism of allopurinol inhibiting the lipid accumulation of macrophages[J]. Chinese Journal of Arteriosclerosis, 2016, 24(4): 355-360.
[19] 张程美, 王高频. 葛根素对oxLDL诱导的THP-1巨噬细胞TLR4-NF-κB信号转导通路的影响[J]. 中国免疫学杂志, 2019, 35(22): 2705-2710. ZHANG Chengmei, WANG Gaopin. Effect of puerarin on oxLDL-induced TLR4-NF-κB signal transduction pathway in THP-1 macrophages[J]. Chinese Journal of Immunology, 2019, 35(22): 2705-2710.
[20] 曹小洁, 张莉莉, 郭露, 等. oxLDL通过PPARγ-ABCG1通路促进血管平滑肌细胞泡沫化[J]. 第三军医大学学报, 2015, 37(4): 325-329. CAO Xiaojie, ZHANG Lili, GUO Lu, et al. Ox LDL promotes vascular smooth muscle cells to form foam cells through PPARγ-ABCG1 signal pathway[J]. Acta Academiae Medicinae Militaris Tertiae, 2015, 37(4): 325-329.
[21] 顾洪丰, 唐朝克, 唐雅玲, 等. 小干扰RNA沉默Toll样受体4表达对慢性温和应激ApoE~(-/-)小鼠腹腔巨噬细胞TLR4/NF-κB途径基因表达的影响[J].中国动脉硬化杂志, 2011, 19(1): 6-12. GU Hongfeng, TANG Chaoke, TANG Yaling, et al. Effects of silencing toll-Like receptor 4 expression on the expression of toll-like receptor 4/nuclear factor-κB signaling pathway in peritoneal macrophages of chronic mild stress apoE-/-mice[J]. Chinese Journal of Arteriosclerosis, 2011, 19(1): 6-12.
[22] 谭玉林, 曾颖, 莫中成, 等. PPARγ对高糖诱导THP-1巨噬细胞CD36表达及脂质蓄积的调节[J]. 中国现代医学杂志, 2014, 24(30): 18-23. TAN Yulin, ZENG Ying, MO Zhongcheng, et al. Regulation of PPARγ on the expression of CD36 and lipid accumulation induced by high glucose in THP-1 macrophages[J]. China Journal of Modern Medicine, 2014, 24(30): 18-23.
[23] 姚海霞, 李亭. PPARγ激动剂对RAW264.7巨噬细胞源性泡沫细胞胆固醇流出的影响[J]. 中国药物与临床, 2016, 16(6): 805-808. YAO Haixia, LI Ting. Effect of PPARγ agonist on cholesterol efflux of RAW264.7 macrophage-derived foam cells[J]. Chinese Remedies & Clinics, 2016, 16(6): 805-808.
[24] 尹凡, 严同, 高峰. 吡格列酮和GW9662对oxLDL孵育的巨噬细胞血脂蓄积和MMP9mRNA表达的影响[J]. 中国医院药学杂志, 2009, 29(19): 1642-1644. YIN Fan, YAN Tong, GAO Feng. Effects of pioglitazone and GW9662 on the lipid accumulation and MMP9 mRNA expression in macrophages co-incubated with oxLDL[J]. Chinese Journal of hospital Pharmacy, 2009, 29(19): 1642-1644.
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!